Close Menu

NEW YORK – IsoPlexis has partnered with the Institute for Systems Biology (ISB) to map functional immune response to COVID-19 at the single-cell level.

The group will use IsoPlexis' single-cell functional platform to analyze immune cells from individuals who have been diagnosed or recovered from COVID-19. The team aims to examine a variety of immune cell types — including various T cells and myeloid cells — to put together a map of the overall response.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.